PPARgamma ligands suppress proliferation of human urothelial basal cells in vitro.
about
PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancerThe peroxisome proliferator activated receptor delta is required for the differentiation of THP-1 monocytic cells by phorbol esterNormal and neoplastic urothelial stem cells: getting to the root of the problemImatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivo.PPARgamma-regulated tight junction development during human urothelial cytodifferentiationIn Vitro Evaluation of Spider Silk Meshes as a Potential Biomaterial for Bladder Reconstruction.Effects of PPARgamma and combined agonists on the urinary tract of rats and other species.Chemotherapeutic drugs induce PPAR-gamma expression and show sequence-specific synergy with PPAR-gamma ligands in inhibition of non-small cell lung cancerThiazolidinediones as anti-cancer agents.PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis.When urothelial differentiation pathways go wrong: implications for bladder cancer development and progression.Scientific Evidence and Controversies About Pioglitazone and Bladder Cancer: Which Lessons Can Be Drawn?FOXA1 and IRF-1 intermediary transcriptional regulators of PPARgamma-induced urothelial cytodifferentiation.Impaired Delta Np63 expression associates with reduced beta-catenin and aggressive phenotypes of urothelial neoplasmsNicotine stimulates human lung cancer cell growth by inducing fibronectin expression.Regulation of prostate-specific antigen by activin A in prostate cancer LNCaP cells.Peroxisome proliferator-activated receptor gamma ligands inhibit cell growth and induce apoptosis in human liver cancer BEL-7402 cells.Neoplastic and non-neoplastic changes in F-344 rats treated with Naveglitazar, a gamma-dominant PPAR alpha/gamma agonist.Urothelial carcinogenesis in the urinary bladder of rats treated with naveglitazar, a gamma-dominant PPAR alpha/gamma agonist: lack of evidence for urolithiasis as an inciting event.Urothelial carcinogenesis in the urinary bladder of male rats treated with muraglitazar, a PPAR alpha/gamma agonist: Evidence for urolithiasis as the inciting event in the mode of action.
P2860
Q21328702-3CF5E2BC-E18B-4BBE-AAB7-9EFBD8611F75Q24806798-04085675-22DB-43E4-AD62-76F4BA0B2A80Q26825948-038DC322-392B-4B90-9737-C467281F0481Q34548738-47B9CAD4-BD87-4FDC-9763-FBA36B88D328Q34863027-4379D4B0-34CB-43F1-9C13-6771454B0777Q35874141-28649E9F-527F-469E-8D32-C10C8ABCCF16Q36210174-FC535BD6-2BB7-4EB2-8D80-3C2D69B0ED84Q36661722-3634FAD9-31CB-4F68-9069-2433A2481FBDQ37010188-3088474F-4965-4154-BEFF-8147B639918EQ37656960-3FFDAA2B-6F0A-4EE6-A66A-05BF81F39741Q37933675-6DFFCAC2-DD8F-4B99-8417-93C68E4904E5Q38122640-2954250D-543B-4DD1-898A-4DAA91C9CFE7Q38288442-0CF96AA6-03FE-4FDC-8F18-110A7FF068E4Q38293557-116E0E74-3D23-4EBE-8116-FDD1E53232ECQ40113803-120F5A44-8A46-4D71-B66E-5E5676753E18Q40592803-19AC98AF-2BB3-49CA-AA58-1DD75CCB28C4Q41905030-C856887A-249B-454C-A9D6-F4E1DDB075CEQ43287595-E98A0D1D-239D-4640-A1AC-9DD39CEAC942Q46599209-5DCFB068-C86C-41B7-B151-2935FF855894Q53338744-8E54A1ED-5050-434D-A8BC-B83243DF5051
P2860
PPARgamma ligands suppress proliferation of human urothelial basal cells in vitro.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
PPARgamma ligands suppress proliferation of human urothelial basal cells in vitro.
@en
PPARgamma ligands suppress proliferation of human urothelial basal cells in vitro.
@nl
type
label
PPARgamma ligands suppress proliferation of human urothelial basal cells in vitro.
@en
PPARgamma ligands suppress proliferation of human urothelial basal cells in vitro.
@nl
prefLabel
PPARgamma ligands suppress proliferation of human urothelial basal cells in vitro.
@en
PPARgamma ligands suppress proliferation of human urothelial basal cells in vitro.
@nl
P2093
P2860
P356
P1476
PPARgamma ligands suppress proliferation of human urothelial basal cells in vitro.
@en
P2093
Guangbin Xia
Kazunori Kihara
Satoru Kawakami
Tetsuo Hayashi
Yasuhisa Fujii
Yukio Kageyama
P2860
P304
P356
10.1002/JCP.10099
P577
2002-06-01T00:00:00Z